Abstract
The PLATO trial has shown that ticagrelor compared to clopidogrel improves survival and decreases risk for stent thrombosis in patients with acute coronary syndrome (ACS). The aim of this study was to investigate whether treatment with ticagrelor is superior to clopidogrel in patients with ACS in
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
